Description
Phase
Phase 3 - a treatment has shown activity against a particular disease, where it is either added to existing treatment or compared to the standard treatment.Inclusion and Exclusion Criteria
Please contact Pui Yan to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- Stanford University Medical Center / Stanford Cancer Center, Stanford, California, 94305
-
Oregon
- Oregon Health Sciences University, Portland, Oregon, 97239
-
Texas
- Methodist Hospital, San Antonio, Texas, 78229
- Southwest Surgical Associates, LLP, Sugarland, Texas, 77479
- Southwest Surgical Associates, L.L.P., Houston, Texas, 77074
- Methodist Hospital, Houston, Texas, 77030
-
Nebraska
- Colon and Rectal Surgery, Inc., Omaha, Nebraska, 68114
- Colon and Rectal Surgery, Inc., Omaha, Nebraska, 68114
-
Missouri
- Washington University School of Medicine, St. Louis, Missouri, 63110
-
Louisiana
- Ochsner Clinic Foundation / Colon and Rectal Surgery, New Orleans, Louisiana, 70121
-
Illinois
- John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, 60612
-
Alabama
- University of South Alabama Medical Center, Mobile, Alabama, 36617
-
Indiana
- Indiana University, Indianapolis, Indiana, 46202
- Indiana University, Indianapolis, Indiana, 46202
-
Kentucky
- University of Louisville, Louisville, Kentucky, 40202
-
Ohio
- Christ Hospital, Cincinnati, Ohio, 45219
Powered by
SC CTSI